Santo Neri

Prognostic models for diffuse large B-cell lymphoma in the rituximab era: a never-ending story

Alessia Bari, Luigi Marcheselli, Stefano Sacchi et al. · Annals of Oncology · 2009 · 89 citations · Full text

Medicine, Hematology, Oncology +16

Clinical relevance of immunophenotype in a retrospective comparative study of 297 peripheral T‐cell lymphomas, unspecified, and 496 diffuse large B‐cell lymphomas

Fortunato Morabito, Andrea Gallamini, Caterina Stelitano et al. · Cancer · 2004 · 41 citations · Full text

Medicine, Hematology, Oncology +13

A randomized trial with melphalan and prednisone versus melphalan and prednisone plus thalidomide in newly diagnosed multiple myeloma patients not eligible for autologous stem cell transplant

Stefano Sacchi, Raffaella Marcheselli, Antonio Lazzaro et al. · Leukemia & lymphoma/Leukemia and lymphoma · 2011 · 28 citations · Full text

Medicine, Oncology, Pharmacology +13

Feasibility, Tolerability and Efficacy of Carfilzomib in Combination with Lenalidomide and Dexamethasone in Relapsed Refractory Myeloma Patients: A Retrospective Real-Life Survey of the Sicilian Myeloma Network

Concetta Conticello, Alessandra Romano, Vittorio Del Fabro et al. · Journal of Clinical Medicine · 2019 · 27 citations · Full text

Medicine, Oncology, Pharmacotherapy +14

Efficacy of biosimilar granulocyte colony-stimulating factor versus originator granulocyte colony-stimulating factor in peripheral blood stem cell mobilization in de novo multiple myeloma patients

Massimo Martino, Anna Grazia Recchia, Tiziana Moscato et al. · Cytotherapy · 2015 · 18 citations

Medicine, Hematology, Immunology +16